Eu­roAPI CEO steps down; Sam­sung Bi­o­log­ics looks to Eu­rope; Mer­ck re­calls pneu­mo­coc­cal vac­cines

Wel­come to End­points News’ man­u­fac­tur­ing news briefs, where we bring you es­sen­tial up­dates on new builds, col­lab­o­ra­tions, re­calls, and more.

This week, we look in­to Eu­roAPI an­nounc­ing its CEO Karl Rot­thi­er will step down by the end of the month, as well as Sam­sung Bi­o­log­ics and Kur­ma col­lab­o­rat­ing on a mul­ti-year agree­ment to de­vel­op bi­o­log­ics. We al­so note Mer­ck’s re­call of its Vaxneu­vance vac­cine, as well as the launch of a new spe­cial­ty phar­ma com­pa­ny, Ave­na­cy.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER